Intracellular growth cytotoxicity of mycobacterium haemophilum in a human epithelial cell line (Hec-1-B)

Infection and Immunity

Volumn 64, Issue 1, 1996, Pages 269-276

  Fischer, Laura J ^a   Quinn, Frederick D ^a   White, Elizabeth H ^a   King, C Harold ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CYTOLYSIN;

ARTICLE; BACTERIUM ISOLATION; CYTOTOXICITY; ENDOTHELIUM CELL; EPITHELIUM CELL; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; MYCOBACTERIUM HAEMOPHILUM; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; THERMOREGULATION;

COLONY COUNT, MICROBIAL; CYTOTOXINS; ENDOMETRIUM; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HEMOLYSIS; HUMANS; MYCOBACTERIUM HAEMOPHILUM; STAINING AND LABELING; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 0030045745     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.1.269-276.1996     Document Type: Article

References (29)

1. Ades, E. W., F. Candal, and R. A. Swerlick. 1992. HMEC-1. establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol 99:683-690.
2. Armstrong, K. L., R. W. James, D. L. Dawson, P. W. Francis, and B. Masters. 1992. Mycobacterium haemophilum causing perihilar or cervical lymphadenitis in healthy children. J. Pediatr. 121:202-205
3. Bernard, E. M., F. F. Edwards, T. E. Kiehn. S. T. Brown, and D. Armstrong. 1993 Activities of antimicrobial agents against clinical isolates of Mycobacterium haemophilum. Antimicrob Agents Chemother, 37:2323-2326.
4. Birkness, K. A., B. L. Swisher, E. H. White, E. G. Long, E. P. Ewing, Jr., and F. D. Quinn. 1995. A tissue culture bilayer model to study the passage of Neisseria menigritidis. Infect. Immun. 63:402-409.
5. Collins, C. H., J. M. Grange, and M. D. Yates. 1986. Unusual opportunistic mycobacteria. Med. Lab. Sci. 43:262-268.
6. Connor, D. H., and F. Lunn. 1966. Buruli ulceration: a clinico-pathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration. Arch. Pathol. 81:183-199.
7. Cott, R. E., D. M. Carter, and T. Sall. 1967. Cutaneous disease caused by atypical mycobacteria. Arch Dermatol. 95:259-268.
8. Damato, J. J., and M. T. Collins. 1984. Radiometric studies with gas-liquid and thin-layer chromatography for rapid demonstration of hemin dependence and characterization of Mycobacterium haemophilum. J. Clin. Microbiol. 20:515-518.
9. Davis, B. R., J. Brumbach, W. J. Sanders, and E. Wolinsky. 1982 Skin lesions caused by Mycobacterium haemophilum. Ann. Intern. Med. 97:723-724
10. Dawson, D. J., and F. Jennis. 1980. Mycobacteria with a growth requirement for ferric ammonia citrate, identified as Mycobacterium haemophilum J. Clin. Microbiol. 11:190-192.
11. Dever, L. L., J. W. Martin, B. Seaworth, and J. H. Jorgensen. 1992. Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin. Infect. Dis. 14:1195-12110.
12. Feldman, R. A., and E. Hershfieid. 1974. Mycobacterial skin infection by an unidentified species. Ann. Intern. Med. 80:445-452.
13. Fischer, L. J., F. D. Quinn, and C. H. King. Unpublished data.
14. Hayman, J., and A. McQueen. 1985. The pathology of Mycobacterium ulcerans infection. Pathology 17:594-600.
15. Kiehn, T. E., and M. Smith. 1994. Mycobacterium haemophilum: an emerging pathogen. Eur J Clin. Microbiol Infect. Dis. 13:925-931.
16. Kiehn, T. E., M. White, K. J. U. Pursell, N. Boone, M. Tsivitis, A. E. Brown, B. Polsky, and D. Armstrong. 1993. A cluster of four cases of Mycobacterium haemophilum infection Eur. J. Clin Microbiol Infect. Dis. 12:114-118.
17. King, C. H., S. Mundayoor, J. T. Crawford, and T. M. Shinnick. 1993. Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity. Infect. Immun 61:2708-2712.
18. Krisjansson, M., V. M. Bieluch, and P. D. Byeff. 1991. Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature. Rev. Infect. Dis. 13:906-910.
19. Males, B. M., T. E. West, and W. R. Bartholomew. 1987. Mycobacterium haemophilum infection in a patient with acquired immune deficiency syndrome J Clin. Microbiol. 25:186-190.
20. Ramakrishnan, L., and S. Falkow. 1994. Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion Infect Immun. 62:3222-3229
21. Read, J. K., C. M. Heggic, W. M. Meyers, and D. H. Connor. 1974. Cytotoxic activity of Mycobacterium ulcerons. Infect Immun 9:1114-1122.
22. Ries, K., G. White, and R. Murdock. 1990 Atypical mycobacterial infection caused by Mycobacterium marinum. N. Engl. J. Med 322:633-633.
23. Rogers, P. L., R. E. Walker, H. C. Lane, F. G. Witebsky, J. A. Kovacs, J. E. Parrillo, and H. Masur. 1988- Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am. J Med 84:640-642
24. Ryan, C. G., and B. W. Dwyer. 1983. New characteristics of Mycobacterium haemophilum J. Clin. Microbiol. 18:976-977.
25. Shepard, C. C. 1956. Growth characteristics of tubercle bacilli and certain other mycobacteria in HeLa cells J. Exp. Med. 105:39-55.
26. Shepard, C. C. 1958. A comparison of the growth of selected mycobacteria in HeLa, monkey kidney, and human amnion cells in tissue culture. J. Exp. Med 107:237-250.
27. Sompolinsky, D., A. Lagziel, D. Naveh, and T. Yankilevitz. 1978. Mycobacterium haemophilum sp. nov, a new pathogen of humans Int. J. Syst. Bacteriol. 28:67-75.
28. Straus, W. L., S. M. Ostroff, D. B. Jernigan, T. E. Kiehn, E. M. Sordillo, D. A. Armstrong, N. Boone, N. Schneider, J. O. Kilburn, V. A. Silcox, V. LaBombardi. and R. C. Good. 1994. Clinical and epidemiological characteristics of Mycobacterium haemoplulum. an emerging pathogen in immunocompromised patients. Ann. Intern. Med. 102:118-125.
29. Street, M. L., I. J. Umbert-Millet, G. D. Roberts, and W. P. Daniel Su. 1990. Nontuberculous mycobacterial infections of the skin. J. Am. Acad. Dermatol. 24:208-215.